Kolexia
Tredaniel Jean Pneumologie
Tredaniel Jean
Pneumologie
Hôpital Saint-Louis
Paris, France
99 Activités
1 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Adénocarcinome Carcinomes Adénocarcinome pulmonaire Métastase tumorale Cellules tumorales circulantes Carcinome bronchogénique

Collaborateurs

Voir plus
Wislez Marie
Wislez Marie
Hôpital Cochin, Paris, France
Westeel-Kaulek Virginie
Westeel-Kaulek Virginie
Hôpital Jean-Minjoz, Besançon, France
Zalcman Gerard
Zalcman Gerard
Hôpital Bichat-Claude-Bernard, Paris, France
Souquet Pierre Jean
Souquet Pierre Jean
Hôpital Lyon Sud, Pierre-Bénite, France

Industries

Voir plus
Roche
2 collaboration(s)
Dernière en 2021
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
STEREO-OS: Extracranial Stereotactic Body Radiation Therapy (SBRT) Added to Standard Treatment Versus Standard Treatment Alone in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases
Essai Clinique (Unicancer)   11 décembre 2023
AcSé: Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations
Essai Clinique (Unicancer)   06 décembre 2023
DETeCTOR: Screening of Tobacco-induced Cancers by Low-dose CT-scanner and Identification of Circulating Tumor Cells
Essai Clinique (Centre Hospitalier Saint Joseph Saint Luc)   06 mars 2023
Sleep Traits, Night Shift Work and Lung Cancer Risk among Women: Results from a Population-Based Case-Control Study in France (The WELCA Study).
International journal of environmental research and public health   04 décembre 2022
Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study.
Targeted oncology   21 septembre 2022
Lung cancer trends and tumor characteristic changes over 20 years (2000-2020): Results of three French consecutive nationwide prospective cohorts' studies.
The Lancet regional health. Europe   29 août 2022
Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.
The Lancet. Oncology   11 août 2022
Grade 3-4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study.
Cancers   11 août 2022
Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-up: Multicentric Randomized Phase III Study of Post-Surgical NSCLC Follow-up
Essai Clinique (Intergroupe Francophone de Cancérologie Thoracique)   09 août 2022
Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   05 mars 2022